Can Rare Cancer Drugs Expect Sales in Japan?: A Prescription Pattern Analysis of Drugs for Chronic Myelogenous Leukemia and Neuroendocrine Tumor. Journal of Regulatory Science, [S. l.], v. 7, p. 1–9, 2019. DOI: 10.21423/JRS-V07SHIBATA. Disponível em: https://regsci-ojs-tamu.tdl.org/regsci/article/view/105.. Acesso em: 17 sep. 2024.